Pharmaceutical unit-dose repackaging and supply chain solutions company Safecor Health, a Vesey Street Capital Partners (VSCP) portfolio company, announced on Monday that it has acquired the US unit-dose packaging business of pharmaceutical company Viatris Inc (NASDAQ:VTRS).
The business was previously called Unit Dose Laboratories (UDL). Established in 1980, it provides unit-dose generic medicines to institutional and long-term care facilities.
The acquisition is expected to be finalised in the first half of 2025, with no immediate action required by customers or partners at this time.
Safecor CEO Mark Saxon, said: "Adding the UDL team, the strong brand recognition, and their capabilities to the Safecor family will further our ongoing goal of providing world-class packaging and supply chain solutions to the manufacturers and health systems we serve. With this addition, we'll immediately increase the number of unit-dose commercial products we offer, and we plan to grow the offering with expanded manufacturer, health system, and wholesaler relationships."
Hikma Pharmaceuticals extends KLOXXADO nasal spray shelf-life 8mg from 24 to 36 months
Sun Pharma's LEQSELVI 8mg tablets receive US FDA approval
Emmaus Life Sciences names new chief executive officer
Biocon seeking partner to test semaglutide generics in China
Amneal announces launch of PEMRYDI RTU, a ready-to-use oncology injectable
ANI Pharmaceuticals launches generic Baclofen Oral Suspension
Biocon Biologics enters five-year partnership with Sandoz Australia
Mallinckrodt names new directors
Rottendorf Pharma enhances operations with Rockwell Automation's FactoryTalk PharmaSuite MES
Apotex launches Teriparatide Injection in US
Teva Pharmaceuticals secures FDA approval for generic Forteo (teriparatide injection)